Kennedy Capital Management, Inc. Arcturus Therapeutics Holdings Inc. Transaction History
Kennedy Capital Management, Inc.
- $4.23 Billion
- Q4 2024
A detailed history of Kennedy Capital Management, Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 10,987 shares of ARCT stock, worth $157,004. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,987
Previous 8,951
22.75%
Holding current value
$157,004
Previous $207,000
10.14%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ARCT
# of Institutions
168Shares Held
26MCall Options Held
163KPut Options Held
173K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$67.1 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$37.9 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.07MShares$29.5 Million0.39% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.07MShares$29.5 Million0.02% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.93MShares$27.6 Million0.29% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $380M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...